Anavex Life Sciences
AVXL
#7563
Rank
A$0.59 B
Marketcap
A$6.62
Share price
-1.12%
Change (1 day)
-43.78%
Change (1 year)

Anavex Life Sciences (AVXL) - Cash on Hand

Cash on Hand as of June 2025 : A$0.15 Billion

According to Anavex Life Sciences 's latest financial reports the company has A$0.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Anavex Life Sciences - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30A$0.19 B-18.65%
2023-09-30A$0.23 B1.31%
2022-09-30A$0.23 B10.24%
2021-09-30A$0.21 B415.39%
2020-09-30A$40.81 M24.23%
2019-09-30A$32.85 M3.5%
2018-09-30A$31.74 M-9.24%
2017-09-30A$34.97 M190.79%
2016-09-30A$12.02 M-44.86%
2015-09-30A$21.81 M162.44%
2014-09-30A$8.31 M2144.96%
2013-09-30A$0.37 M3274.3%
2012-09-30A$0.01 M-92.06%
2011-09-30A$0.13 M-49.62%
2010-09-30A$0.27 M-32.1%
2009-09-30A$0.4 M4936.73%
2008-09-30A$0 M28607.42%
2007-09-30A$0 M-99.83%
2006-09-30A$0.01 M1179.05%
2005-09-30A$0 M-96.72%
2004-09-30A$0.03 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Ligand Pharmaceuticals
LGND
A$1.01 B 569.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.32 B 110.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$0.63 B 316.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A$3.79 M-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA